Clinical Trial Update: Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome [NA]

View source ↗

Summary

A clinical trial investigating an interleukin-6 assay to predict failure of spontaneous breathing in patients with COVID-19–related acute respiratory distress s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Acute Respiratory Distress Syndrome

Snippet

Sponsor: Centre Hospitalier Henri Duffaut - Avignon | Conditions: COVID-19 Acute Respiratory Distress Syndrome | NA | Status: TERMINATED